MicroRNA-22-3p Regulates the Apoptosis of Lens Epithelial Cells Through Targeting KLF6 in Diabetic Cataracts
Open Access
- 1 May 2023
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 12 (5) , 9
Abstract
Purpose: The purpose of this study was to identify novel abnormally expressed microRNAs (miRNAs) and their downstream target in diabetic cataract (DC). Methods: General feature, fasting blood glucose, glycosylated hemoglobin, and type A1c (HbA1c) expression level of patients were collected. DC capsular tissues were obtained from patients and the lens cells (HLE-B3) exposed to different concentrations of glucose were used to simulate the model in vitro. Both mimic and inhibitor of miR-22-3p were transferred into HLE-B3 to up- and downregulate miR-22-3p expression, respectively. The cellular apoptosis was evaluated by quantitative real-time polymerase chain reaction (qRT-PCR), Western blot, and immunofluorescence. The downstream target gene of miR-22-3p was identified by dual luciferase reporter. Results: In DC capsules and HLE-B3 under hyperglycemia, miR-22-3p showed a significant downward trend. The expression of BAX was upregulated and the BCL-2 was downregulated following high glucose. The expression of BAX was significantly down- or upregulated in HLE-B3 cells following transfection of mimic or inhibitor of miR-22-3p, respectively. Conversely, BCL-2 was significantly increased or decreased. Dual luciferase reporter assay showed that miR-22-3p directly targeted Krüppel Like Factor 6 (KLF6) to regulate cell apoptosis. In addition, the expression of KLF6 were significantly up- or downregulated following transfection of inhibitor or mimic of miR-22-3p. Conclusions: This study suggested that miR-22-3p could inhibit lens apoptosis by targeting KLF6 directly under high glucose condition. The miR-22-3p/KLF6 signal axis may provide novel insights into the pathogenesis of DC. Translational Relevance: Differential expression of miR-22-3p may account for the pathogenesis of DC and lead to a new therapeutic strategy for DC.Keywords
This publication has 45 references indexed in Scilit:
- miR-22 represses cancer progression by inducing cellular senescenceJournal of Cell Biology, 2011
- Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of α-crystallin chaperone activityThe Journal of Nutritional Biochemistry, 2009
- The role of KLF6 and its splice variants in cancer therapyDrug Resistance Updates, 2009
- A role for microRNAs in maintenance of mouse mammary epithelial progenitor cellsGenes & Development, 2007
- Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal DisseminationClinical Cancer Research, 2006
- Developmentally Regulated Expression of KLF6 in the Mouse Cornea and LensInvestigative Ophthalmology & Visual Science, 2004
- A new role for the Krüppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein functionOncogene, 2004
- Krüppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer CellsCancer Research, 2004
- Contribution of Polyol Pathway to Diabetes-Induced Oxidative StressJournal of the American Society of Nephrology, 2003
- KLF6 , a Candidate Tumor Suppressor Gene Mutated in Prostate CancerScience, 2001